Investigation on Suicide Risk Factors of Patients With Mood Disorders
1 other identifier
observational
300
1 country
1
Brief Summary
This study investigates the level and distribution of suicide risk and learned suicide ability of patients with mood disorders, investigates the related risk factors of suicide and suicide ability formation of patients with mood disorders from multiple dimensions (biological, psychological, social and clinical perspectives) and clarifies their importance, forms a list of suicide risk factors, and establishes a prediction model of learned suicide ability formation. Upon enrollment, participants will undergo comprehensive assessments including blood and urine sample collection and scale evaluation. The collection of scientific blood and urine is mainly used for the exploration of molecular mechanism of disease occurrence and development, the discovery and verification of biomarkers. Scale evaluation includes: Beck Scale for Suicide Ideation , Columbia Suicide Severity Rating Scale,, Hamilton Depression Rating Scale , Hamilton Anxiety Rating Scale, PHQ-9, GAD-7, Personal and Social Function Scale , Schihan Disability Scale , Emotional Adjustment Difficulty Scale , Acquired Capability for Suicide Scale, Interpersonal Needs Questionnaire , Ottawa Self-Injury Scale, Chinese version of Stress Perception Scale and Beck Hopelessness Scale . Follow-up was carried out for 3 months, including whether suicide/self-injury occurred, current status, and some baseline questionnaires (such as BSI-CV, GAD-7, PHQ-9, HAMD-17,HAMA, etc.).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 31, 2025
CompletedFirst Submitted
Initial submission to the registry
April 5, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
April 22, 2026
April 1, 2026
1.7 years
April 5, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Columbia Suicide Severity Rating Scale
Columbia Suicide Severity Rating Scale (C-SSRS) is a tool for evaluating the risk of individual suicide. It includes a series of questions to evaluate the frequency, intensity, persistence and concreteness of individual suicide behavior in the past period of time. The purpose of C-SSRS scale is to distinguish between suicidal ideation and suicidal attempt and higher scores mean a worse outcome. Developed by researchers from Columbia University, the scale is widely used in clinical and research fields to help identify and manage suicide risks.
baseline, 3 months
Secondary Outcomes (8)
Beck Scale for Suicide Ideation
baseline, 3 months
Hamilton Depression Rating Scale
baseline, 3 months
Hamilton Anxiety Rating Scale
baseline, 3 months
Patient Health Questionnare
baseline, 3 months
Generalized Anxiety Disorder
baseline, 3 months
- +3 more secondary outcomes
Study Arms (1)
patients with mood disorders
1. Age: 16 to 60 years old; 2. seeing a doctor in a psychiatric clinic or a general hospital; 3. Willing to cooperate in this research project; 4. Sign the informed consent form (minors also need to obtain the informed consent signature of the guardian); 5. Meet the diagnostic criteria of ICD-11 mood disorder.
Eligibility Criteria
This study will recruit 300 patients meeting the diagnostic criteria of ICD-11 mood disorder.The 300 subjects, aged16 to 60 years old, come from Tianjin Anding Hospital's inpatient/outpatient services and must consent to participate. Exclusion Criteria are as follows:(1) unable to understand the contents of the questionnaire;(2) Serious organic diseases such as cardiovascular disease, brain disease, liver disease and kidney disease, and weak body, which affect the respondents of the questionnaire;(3) Other circumstances that make it impossible or unwilling to cooperate with the completion of the questionnaire.
You may qualify if:
- Age: 16 to 60 years old;
- seeing a doctor in a psychiatric clinic or a general hospital;
- Willing to cooperate in this research project;
- Sign the informed consent form (minors also need to obtain the informed consent signature of the guardian);
- Meet the diagnostic criteria of ICD-11 mood disorder.
You may not qualify if:
- unable to understand the contents of the questionnaire;
- Serious organic diseases such as cardiovascular disease, brain disease, liver disease and kidney disease, and weak body, which affect the respondents of the questionnaire;
- Other circumstances that make it impossible or unwilling to cooperate with the completion of the questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tianjin Anding Hospital
Tianjin, Tianjin Municipality, 300000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2026
First Posted
April 13, 2026
Study Start
December 31, 2025
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
April 22, 2026
Record last verified: 2026-04